Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesPompholyx or dyshidrosis
Expert Review of Dermatology, 08/14/09
Wollina U – Pompholyx is an inflammatory vesicobullous disorder of the palms and soles. Pompholyx treatment is challenging: topical therapy is based on corticosteroids and calcineurin inhibitors. Topical and systemic photochemotherapy and high–dose UVA–1 irradiation have been successfully used. Systemic therapy is often necessary in advanced cases of pompholyx. Corticosteroids are commonly used, sometimes combined with immunosuppressants. Alitretinoin has efficacy in chronic hand eczema including pompholyx. Another evolving treatment seems to be the intradermal injection of botulinum toxin. Prevention requires antibiosis in case of suspected secondary infection and aggressive anti–inflammatory treatment.
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria
Annals of Allergy, Asthma, and Immunology, 12/16/09
Bacterial Burden of Worn Therapeutic Silver Textiles for Neurodermitis Patients and Evaluation of Efficacy of Washing
Skin Pharmacology and Applied Skin Physiology, 12/16/09
Integrated, multidisciplinary care for hand eczema: design of a randomized controlled trial and cost-effectiveness study
BMC Public Health, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor